Sign in
or
Register
0
Add listing
View all results
No results
News
Events
The industry
arrow_drop_down
Industry overview
Industrial biotech
Swiss Biotech Report
Success Stories
Company directory
Jobs
Networking platforms
Newsletter
Association
arrow_drop_down
Mission and services
Members
Academy
Partners
Team
Media
Add listing
Rayaldee
Product
prev
next
Leave a review
Bookmark
Share
Report
prev
next
Indicaton
Secondary hyperparathyroidism in patients with vitamin D insufficiency
Therapeutic indications
Metabolic disorder
Type of product
Small molecule
Company
Vifor Pharma Management Ltd.
Table
Phase
Filing
Partnering status
Not partnered
Available in
Ex-US
You may also be interested in
Invokana
Diabetic Kidney Disease
Marketed
Retacrit
Short-acting Erythropoisesis-Stimulating agents.
Marketed
Mircera
Symptomatic anaemia associated with CKD. Long-acting ESA.
Marketed
Cart
×
View all results
No results
Facebook
Twitter
WhatsApp
Telegram
Pinterest
LinkedIn
Tumblr
VKontakte
Mail
Copy link
This site uses cookies:
Find out more.
Accept